Novartis lifts outlook, citing cancer, inflammatory drugs
Drugmaker sees revenue growing 6% per year through to 2029
Drugmaker sees revenue growing 6% per year through to 2029
Continent’s top firms drove most of European equity gains last year
The shares dropped 4 per cent, tempering gains of 9 per cent so far this year, as analysts pointed to higher-than-expected costs and some disappointment over the 2024 goal.
Pharmaceutical-related products accounted for almost two-thirds of Irish goods exports last year
Higher interest rates and ESG requirements see Dublin 4 scheme’s capital value fall to below replacement cost level of €170 per square foot
Action against generics group Mylan continues after terms agreed with rival generics player Accord Healthcare in patent infringement case
When staff at the Irish arm of the Swiss pharma company Novartis were asked for feedback on wellness initiatives, health screening was high on the list
Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest pharma shake-up in decades
US consumer price index comes in marginally below expectations, with core prices as expected
The sector is dealing with a double whammy of an economic downturn and changes in working patterns
Agency’s figures also point to partial displacement of trade following UK’s exit from EU
Revenue fails to convince court that Swiss company should not be refunded
The medicine is used in the treatment of relapsing-remitting multiple sclerosis and contains the active ingredient fingolimod
Pharma group has moved to new global structure in 2022 in a bid to cut costs
Irish company’s software is designed to help make pathology more efficient
Drug companies scrambling to meet surging demand for patches and gels
More than 16,000 registered to take part in programme broadcast from Dublin
In lab tests the drug maintained its antiviral activity against all variants of concern
Iseq closes in positive territory despite Ryanair warning
CSO figures reveal computer services and chemicals dominate State’s exports
FTSE 100 rallies as Bank of England leaves interest rates unchanged
The Swiss pharma giant warned it expected Sandoz’s operating income to fall faster than previously expected this year
Irish scientists and companies are working on next-generation cancer therapies
Dublin-headquartered company helps patients better adhere to medication schedules
Mr Bodson, who joins from Novartis, has also served at Sainsburys Argos, EMI and Amazon
Vaccine OK raises hope of quicker recovery
CSO figures point to sharp increase in imports from North in wake of UK’s EU exit
Iseq advances 2.2% for back-to-back session gains after gloomy start to the trading week
Parkinson’s Association, My Waste see benefits of programme
SFI has provided €40m in funding to projects tackling challenges in healthcare, climate change and financial services
Lynparza may be effective medication for patients with BRCA genetic mutation
Drug sales hit as people skip doctor visits during Covid-19 crisis
Company seeking alternative roles for staff after loss of contract with Gilead Sciences
Texas to drop mask rule as states seek to relax Coronavirus restrictions
Exports of medical and pharmaceutical products drive record performance
New BioNTech production site will have capacity to produce 750m doses annually
Pledge will only be met if pharma companies stick to delivery commitments
Additional supply part of deal announced by European Commission president last month
Canada, Japan and South Korea warn against grab for vaccine supplies
Value of Irish exports increases by €2bn in November on back of pharma sector
Pharma giant strikes deal for Swiss group SGS to take over laboratory facilities
Kingspan plunged 12% after company announces retirement of head of insulation boards business
Latest trade numbers detail soaring demand for medical and pharmaceutical products
BioNTech’s work could provide a major breakthrough in the fight against the pandemic
Search for a vaccine started after coronavirus outbreak in Wuhan
Latest trade figures show value of exports rose by 6 per cent to over €14 billion
Key players in Dublin-based start-up were involved in successful Inflazome venture
ESRI finds labour-intensive domestic sector hit harder by restrictions, shedding jobs
Inflazome, company he founded with Luke O’Neill, sold to Roche for an initial €380m
Cantillon: Venture capital business sells Inflazome to Roche for €380m
Company developing medicines for chronic inflammatory diseases such as Alzheimer’s
Iseq climbs on Kingspan earnings, while airlines receive respite from recent falls
Crosswords & puzzles to keep you challenged and entertained
Inquests into the nightclub fire that led to the deaths of 48 people
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices